| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.13 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.13 | 0.6 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |